Hans-Peter Gschwind
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 4
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Felix Waldmeier (5 shared papers)Markus Zollinger (3 shared papers)Gerhard Groß (2 shared papers)Bin Peng (1 shared paper)Monique Ben‐Am (1 shared paper)Peter Zbinden (1 shared paper)Michael Seiberling (1 shared paper)Rolf Pokorny (1 shared paper)
- Journals
- Drug Metabolism and Disposition (4 papers)Metallomics (2 papers)European Journal of Pharmaceutical Sciences (2 papers)The Journal of Steroid Biochemistry and Molecular Biology (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- SwitzerlandUnited StatesRussia
In The Last Decade
Hans-Peter Gschwind
15 papers receiving 460 citations
Peers
Comparison fields: 5 of 80
- Hematology 138
- Genetics 79
- Pharmacology 41
- Gastroenterology 19
- Oncology 76
Countries citing papers authored by Hans-Peter Gschwind
This map shows the geographic impact of Hans-Peter Gschwind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans-Peter Gschwind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans-Peter Gschwind more than expected).
Fields of papers citing papers by Hans-Peter Gschwind
This network shows the impact of papers produced by Hans-Peter Gschwind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans-Peter Gschwind. The network helps show where Hans-Peter Gschwind may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans-Peter Gschwind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 187 | |
| 2 | 2006 | 60 | |
| 3 | 2009 | 56 | |
| 4 | 2010 | 40 | |
| 5 | 2014 | 25 | |
| 6 | 2013 | 23 | |
| 7 | 2001 | 21 | |
| 8 | 2007 | 18 | |
| 9 | 1979 | 14 | |
| 10 | 1990 | 12 | |
| 11 | 2012 | 6 | |
| 12 | 2014 | 4 | |
| 13 | 1992 | 3 | |
| 14 | 2018 | 1 | |
| 15 | 2003 | 1 |
About Hans-Peter Gschwind
Hans-Peter Gschwind is a scholar working on Oncology, Molecular Biology, Genetics, Pharmacology and Hematology, having authored 15 papers that have together received 471 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Epilepsy research and treatment (2 papers), Estrogen and related hormone effects (2 papers), Iron Metabolism and Disorders (2 papers), Amino Acid Enzymes and Metabolism (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Hematology (138 citations), Genetics (79 citations), Pharmacology (41 citations), Gastroenterology (19 citations) and Oncology (76 citations). Hans-Peter Gschwind has collaborated with scholars based in Switzerland, United States and Russia. Frequent co-authors include Felix Waldmeier, Markus Zollinger, Gerhard Groß, Bin Peng, Monique Ben‐Am, Peter Zbinden, Michael Seiberling, Rolf Pokorny, Ulrike Pfaar and Michael Hayes. Their work appears in journals such as Drug Metabolism and Disposition, Metallomics, European Journal of Pharmaceutical Sciences, The Journal of Steroid Biochemistry and Molecular Biology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.